AHP Protonix OTC Switch Considered As Long-Term Possibility
This article was originally published in The Tan Sheet
Executive Summary
American Home Products is interested in the Rx-to-OTC switch possibilities of its proton pump inhibitor Protonix but is unlikely to pursue nonprescription status for the drug in the near-term.